Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
Saved in:
| Title: | Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer. |
|---|---|
| Authors: | Buzdar A; The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA. abuzdar@mdanderson.org, Hayes D, El-Khoudary A, Yan S, Lønning P, Lichinitser M, Gopal R, Falkson G, Pritchard K, Lipton A, Wolter K, Lee A, Fly K, Chew R, Alderdice M, Burke K, Eisenber P |
| Corporate Authors: | Droloxifene 301 Study Group |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2002 May; Vol. 73 (2), pp. 161-75. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print Cited Medium: Print ISSN: 0167-6806 (Print) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 12088118 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Buzdar+A%22">Buzdar A</searchLink>; The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA. abuzdar@mdanderson.org<br /><searchLink fieldCode="AU" term="%22Hayes+D%22">Hayes D</searchLink><br /><searchLink fieldCode="AU" term="%22El-Khoudary+A%22">El-Khoudary A</searchLink><br /><searchLink fieldCode="AU" term="%22Yan+S%22">Yan S</searchLink><br /><searchLink fieldCode="AU" term="%22Lønning+P%22">Lønning P</searchLink><br /><searchLink fieldCode="AU" term="%22Lichinitser+M%22">Lichinitser M</searchLink><br /><searchLink fieldCode="AU" term="%22Gopal+R%22">Gopal R</searchLink><br /><searchLink fieldCode="AU" term="%22Falkson+G%22">Falkson G</searchLink><br /><searchLink fieldCode="AU" term="%22Pritchard+K%22">Pritchard K</searchLink><br /><searchLink fieldCode="AU" term="%22Lipton+A%22">Lipton A</searchLink><br /><searchLink fieldCode="AU" term="%22Wolter+K%22">Wolter K</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+A%22">Lee A</searchLink><br /><searchLink fieldCode="AU" term="%22Fly+K%22">Fly K</searchLink><br /><searchLink fieldCode="AU" term="%22Chew+R%22">Chew R</searchLink><br /><searchLink fieldCode="AU" term="%22Alderdice+M%22">Alderdice M</searchLink><br /><searchLink fieldCode="AU" term="%22Burke+K%22">Burke K</searchLink><br /><searchLink fieldCode="AU" term="%22Eisenber+P%22">Eisenber P</searchLink> – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Droloxifene+301+Study+Group%22">Droloxifene 301 Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2002 May; Vol. 73 (2), pp. 161-75. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0167-6806 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=12088118 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1023/a:1015229630260 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 161 Titles: – TitleFull: Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Buzdar A – PersonEntity: Name: NameFull: Hayes D – PersonEntity: Name: NameFull: El-Khoudary A – PersonEntity: Name: NameFull: Yan S – PersonEntity: Name: NameFull: Lønning P – PersonEntity: Name: NameFull: Lichinitser M – PersonEntity: Name: NameFull: Gopal R – PersonEntity: Name: NameFull: Falkson G – PersonEntity: Name: NameFull: Pritchard K – PersonEntity: Name: NameFull: Lipton A – PersonEntity: Name: NameFull: Wolter K – PersonEntity: Name: NameFull: Lee A – PersonEntity: Name: NameFull: Fly K – PersonEntity: Name: NameFull: Chew R – PersonEntity: Name: NameFull: Alderdice M – PersonEntity: Name: NameFull: Burke K – PersonEntity: Name: NameFull: Eisenber P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2002 May Type: published Y: 2002 Identifiers: – Type: issn-print Value: 0167-6806 Numbering: – Type: volume Value: 73 – Type: issue Value: 2 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |